Cleerly LABS vs Viz AAA
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to meticulously quantify and characterize atherosclerosis and stenosis. This tool is ideal for cardiologists and radiologists focused on personalized heart disease management, tracking disease progression, and detailed risk assessment based on coronary plaque burden.
View Cleerly LABS →Choose Viz AAA if…
Choose Viz AAA if your priority is the rapid, AI-powered detection and automated triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, particularly in emergency or high-volume settings. This solution excels at accelerating diagnosis, enabling real-time alerts, and streamlining care coordination among multidisciplinary teams for urgent vascular interventions.
View Viz AAA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Viz AAA |
|---|---|---|
| Pricing | Varies | Enterprise (hospital/health system) |
| Deployment | Cloud, On-premise | Cloud-based, integrates with PACS and EHR systems. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAViz AAA emphasizes real-time alerts, mobile access to high-fidelity imaging, and a HIPAA-compliant communication platform, which streamlines acute care coordination and immediate actionability for care teams. Cleerly LABS, while offering a web-based platform with 3D visualization for detailed analysis, does not highlight the same level of immediate, collaborative workflow integration.
Clinical Value
TieBoth tools provide significant clinical value in their respective specialties. Cleerly LABS offers comprehensive, longitudinal assessment and personalized management for chronic coronary artery disease, backed by studies showing improved diagnostic accuracy and changes in clinical management. Viz AAA excels in rapid, accurate detection and triage of acute, life-threatening abdominal aortic aneurysms, with strong sensitivity and specificity in real-world data. Their distinct applications make a direct comparison of 'more' value difficult.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent, per-analysis pricing, including a current discount and growing insurance coverage from major payors and Medicare, which allows for a clearer cost-benefit assessment per patient. Viz AAA operates on a less transparent subscription model with no public pricing tiers, making it harder for potential customers to evaluate its value proposition upfront.
Enterprise Readiness
Viz AAAWhile both are FDA-cleared, HIPAA compliant, and cloud-based with integration capabilities, Viz AAA is part of the broader Viz AORTIC Module and the Viz.ai platform, which is deployed in over 2,000 hospitals across the U.S. and Europe. This indicates a more established and scalable enterprise footprint for comprehensive aortic pathology solutions and broader hospital system integration.
Innovation
Cleerly LABSCleerly LABS demonstrates greater innovation by moving beyond simple stenosis detection to offer comprehensive quantification and characterization of coronary plaque (volume, type) and the ability to track disease progression over time. This enables a more personalized and proactive approach to heart disease management, aiming to prevent heart attacks.
Support & Docs
Viz AAAViz AAA offers more extensive and immediate support, including 24/7/365 urgent phone support, email, and in-app assistance, complemented by a dedicated customer success team with specialists for workflow optimization. Cleerly LABS provides standard business-hour client support via a form and general contact information, which is less comprehensive for critical healthcare environments.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Viz AAA |
|---|---|---|
| Primary Function/Target Condition | Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. | Detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. |
| AI-powered Analysis Focus | CCTA image analysis for comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and ischemia detection (with Cleerly ISCHEMIA module). | Automatic detection of suspected AAA from CTA scans and automated triage and prioritization of cases. |
| Key Output/Benefit | Comprehensive coronary plaque assessment, stenosis detection, 3D visualization, personalized heart disease risk assessment, tracking disease progression. | Automated detection of suspected AAA, automated triage and prioritization, real-time alerts to care teams, mobile access to imaging and patient information. |
| Integration Capabilities | Integration with PACS, RIS, EHR via Cleerly Proxy. | Integration into existing hospital workflows, HIPAA-compliant communication platform for multidisciplinary teams. |
| Specialties Served | Cardiology, Radiology. | Emergency Medicine, Radiology, Vascular Surgery. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Viz AAA.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Viz AAA
Backers
Who funded each tool's parent company.